OneMedNet
ONMD
Market cap $23.9M

0.8491 USD

-0.0254

2.90%

At close Nov 19, 4:00 PM EST

After hours

0.8310

-0.0181

2.13%

1 day

-2.90%

5 days

-10.62%

1 month

21.30%

3 months

-32.07%

6 months

80.66%

Year to date

14.59%

1 year

-82.09%

5 years

-83.95%

10 years

-83.95%

About: OneMedNet Corp is a healthcare software company with solutions focused on digital medical image management, exchange, and sharing. It is a global provider of clinical imaging innovation and curator of regulatory-grade Imaging Real-World Data or iRWDTM. OneMedNet's innovative solutions connect healthcare providers and patients satisfying a crucial need within the Life Sciences field offering direct access to clinical images and the associated contextual patient record.

Employees: 20

Industrials Commercial Physical & Biological Research

0

Funds holding %

of 6,743 funds

–

Analysts bullish %

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

167% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 3

36% more funds holding

Funds holding: 14 [Q2] → 19 (+5) [Q3]

7.39% more ownership

Funds ownership: 17.82% [Q2] → 25.22% (+7.39%) [Q3]

11% less capital invested

Capital invested by funds: $4.15M [Q2] → $3.67M (-$473K) [Q3]

67% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 6

See Fund Rankings

Research analyst outlook

We haven’t received any recent analyst ratings for ONMD.

See Analyst Rankings

Financial journalist opinion

OneMedNet Announces Continued Investment into Bitcoin

MINNEAPOLIS, Nov. 12, 2024 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) ("OneMedNet" or the "Company"), a pioneer in curating regulatory-grade Real World Data (RWD) including electronic health records, laboratory results, and medical imaging, has announced an additional strategic investment in Bitcoin. This investment is designed to enhance the company's financial resilience and support the expansion of its cutting-edge iRWD™ platform.

OneMedNet Announces Continued Investment into Bitcoin

OneMedNet Announces Board Member Transition to Drive Growth Post-IPO

MINNEAPOLIS, Oct. 02, 2024 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet” or the “Company”), the leading curator of regulatory-grade Real World Data (RWD), is pleased to announce a strategic refresh of its Board of Directors following the successful transition to a publicly traded entity. This move reinforces our commitment to dynamic leadership and active engagement as we accelerate growth in this new phase.

OneMedNet Announces Board Member Transition to Drive Growth Post-IPO

OneMedNet Announces Additional $1.7 Million Private Placement

MINNEAPOLIS, Sept. 26, 2024 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet” or the “Company”), the leading curator of regulatory-grade Real World Data ("RWD"), inclusive of electronic health records, laboratory results and, uniquely, medical imaging, today announced that it has entered into a securities purchase agreement with an affiliate of Off the Chain Capital (collectively, “Off the Chain”) in a follow-on private placement that resulted in gross proceeds of approximately $1.7 million, before deducting fees and expenses payable by the Company.

OneMedNet Announces Additional $1.7 Million Private Placement

OneMedNet Announces Receipt of Nasdaq Notices Regarding Delayed Forms 10-Q

MINNEAPOLIS, Sept. 12, 2024 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet” or the “Company”), the leading curator of regulatory-grade Real World Data ("RWD"), inclusive of electronic health records, laboratory results and, uniquely, medical imaging, today announced the Company received an expected notice (the “First Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, due to the Company's failure to timely file its Form 10-Q for the fiscal quarter ended June 30, 2024 (the “Form 10-Q”) with the Securities and Exchange Commission (the “SEC”), the Company is not in compliance with Nasdaq's continued listing requirements under Nasdaq Listing Rule 5250(c)(1) (the “Rule”), which requires the timely filing of all required periodic reports with the SEC.

OneMedNet Announces Receipt of Nasdaq Notices Regarding Delayed Forms 10-Q

OneMedNet appoints new CFO

MINNEAPOLIS, Sept. 10, 2024 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet” or the “Company”), the leading curator of regulatory-grade Real World Data (RWD), has announced that Bob Golden has joined the OneMedNet Executive Team as Chief Financial Officer spearheading all aspects of the company's financial and accounting operations while continuing to serve as a member of the Board of Directors.

OneMedNet appoints new CFO

OneMedNet Revolutionizes Data Curation with AI, Boosting Efficiency up to 5X

MINNEAPOLIS, Aug. 09, 2024 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet” or the “Company”), the leading curator of regulatory-grade Real World Data (RWD), has successfully integrated its proprietary AI technology into its data curation process, ensuring rapid and precise de-identification of patient data. This innovation, coupled with other changes undertaken by the Company, has significantly reduced OneMedNet's operational costs, enabling the company to process vast amounts of clinical data in minutes rather than hours. Additionally, OneMedNet can now deliver longitudinal clinical data and images to Life Science organizations up to five times faster than before, as measured from the end-to-end data curation process, significantly expediting delivery.

OneMedNet Revolutionizes Data Curation with AI, Boosting Efficiency up to 5X

OneMedNet Announces $4.6 Million Private Placement

Institutional investors include affiliates of Off the Chain Capital and Discovery Capital Management Institutional investors include affiliates of Off the Chain Capital and Discovery Capital Management

OneMedNet Announces $4.6 Million Private Placement

Cytel Unveiled as OneMedNet's Newest Alliance Partner

Cytel's software products and services are utilized by hundreds of life science organizations, including the top 30 biopharmaceutical companies Cytel's software products and services are utilized by hundreds of life science organizations, including the top 30 biopharmaceutical companies

Cytel Unveiled as OneMedNet's Newest Alliance Partner

OneMedNet Partners with Leading Clinical Trial Design and Software Company in Significant Data License Agreement

Partner's software products and services are utilized by hundreds of life science organizations, including the top 30 biopharmaceutical companies Partner's software products and services are utilized by hundreds of life science organizations, including the top 30 biopharmaceutical companies

OneMedNet Partners with Leading Clinical Trial Design and Software Company in Significant Data License Agreement

OneMedNet Significantly Expands Industry Access to Proprietary iRWD™ Network and Platform by Joining AWS Partner Network

Secures new life science company customer through this globally recognized and trusted new channel Secures new life science company customer through this globally recognized and trusted new channel

OneMedNet Significantly Expands Industry Access to Proprietary iRWD™ Network and Platform by Joining AWS Partner Network

See News Rankings

Charts implemented using Lightweight Charts™